This page contains brief information about amivantamab-vmjw and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Amivantamab-vmjw is approved to treat:
- Non-small cell lung cancer (NSCLC) that has spread and got worse during or after platinum chemotherapy. It is used in adults whose cancer has certain EGFR gene mutations.
Amivantamab-vmjw is also being studied in the treatment of other types of cancer.
More About Amivantamab-vmjw
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Amivantamab-vmjw - Check for trials from NCI's list of cancer clinical trials now accepting patients.